
Alkem Laboratories Investor Relations Material
Latest events

Q4 24/25
Alkem Laboratories
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Alkem Laboratories Limited
Access all reports
Alkem Laboratories Limited is a pharmaceutical company engaged in the development, manufacturing, and marketing of generic and branded medicines. The company’s product portfolio spans multiple therapeutic areas, including anti-infectives, gastroenterology, cardiology, neurology, and pain management. It operates a network of research and manufacturing facilities to supply domestic and international markets. The company is headquartered in Mumbai, India, and its shares are listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE).
Key slides for Alkem Laboratories Limited


Q4 24/25
Alkem Laboratories Limited


Q3 24/25
Alkem Laboratories Limited
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
ALKEM
Country
🇮🇳 India